CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,138 | 114,978 | ||
| 2017-07-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,127 | 113,840 | ||
| 2017-06-30 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,115 | 112,713 | ||
| 2017-06-12 | BRENNAN MURRAY Director | Option exercise | +15,000 | $4.85 | $73K | 68,114 |
| 2017-06-12 | BRENNAN MURRAY Director | Shares withheld for taxes | −13,300 | $5.47 | $73K | 54,814 |
| 2017-06-12 | BRENNAN MURRAY Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2017-06-12 | CANNON JAMES ANTHONY Director | Option exercise | +15,000 | $4.85 | $73K | 367,502 |
| 2017-06-12 | CANNON JAMES ANTHONY Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2017-06-12 | Fowler Wyche Director | Option exercise | +15,000 | $4.85 | $73K | 155,850 |
| 2017-06-12 | Fowler Wyche Director | Shares withheld for taxes | −13,980 | $5.47 | $76K | 141,870 |
| 2017-06-12 | Fowler Wyche Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2017-06-12 | WEISER MICHAEL Director | Option exercise | +15,000 | $4.85 | $73K | 218,670 |
| 2017-06-12 | WEISER MICHAEL Director | Shares withheld for taxes | −13,300 | $5.47 | $73K | 205,370 |
| 2017-06-12 | WEISER MICHAEL Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2017-06-01 | BELBEL CAESAR J COO, CLO, and Secretary | Shares withheld for taxes | −16,666 | $6.11 | $102K | 173,551 |
| 2017-05-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,104 | 111,598 | ||
| 2017-05-05 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −132,000 | $7.12 | $940K | 1,077,291 |
| 2017-04-28 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,094 | 110,494 | ||
| 2017-03-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,083 | 109,400 | ||
| 2017-02-28 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,072 | 108,317 |
Page 14 of 16 · 304 trades